|Bid||38.66 x 1100|
|Ask||38.97 x 1800|
|Day's Range||38.60 - 39.03|
|52 Week Range||31.60 - 41.58|
|Beta (5Y Monthly)||0.65|
|PE Ratio (TTM)||10.16|
|Forward Dividend & Yield||2.98 (7.67%)|
|Ex-Dividend Date||Jul 08, 2021|
|1y Target Est||49.56|
Shareholders of tobacco giant British American Tobacco (NYSE: BTI) had to be happy with the month of March, as shares gained 11.6% in the period, according to data provided by S&P Global Market Intelligence. In mid-February, when the company reported its fiscal 2020 results, BAT updated investors on several aspects of its "new categories" segment. Its Vuse vapor revenue grew 85%, for example.
Organigram Holdings Inc. said Tuesday it has acquired The Edibles & Infusions Corp. for C$22 million, plus up to an additional C$13 million in shares, in its first deal since receiving a C$221 million investment from British American Tobacco PLC.
The stocks of several cannabis producers have more than doubled just since the start of the year, including Organigram Holdings (NASDAQ: OGI). Organigram got an added boost from news of a strategic partnership in March, helping its shares gain 14.5% in the month, according to data provided by S&P Global Market Intelligence. On March 11, news that Organigram and tobacco giant British American Tobacco (NYSE: BTI) formed a business alliance caused the stock to spike almost 40% that day.